What is the 340B Program?
Allison Hoffman, Professor of Law at UPenn Law, joins CareTalk to discuss the 340B Program. The 340B drug pricing program requires drug companies to provide outpatient drugs to eligible healthcare organizations and covered entities at discounted prices. Hoffman discusses how the 340B program works and why it is so important. She also shares her insights on how the 340B program could be improved. This is a must-listen for anyone who wants to learn more about this significant program. ABOUT CARETALK CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare system. Join co-hosts John Driscoll (CEO, CareCentrix) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCH Become a CareTalk Podcast sponsor: https://www.caretalkpodcast.com/work-... Guest appearance requests: https://www.caretalkpodcast.com/conta... Visit us at https://www.caretalkpodcast.com FOLLOW Spotify: https://open.spotify.com/show/2GTYhbN.... Apple Podcasts: https://podcasts.apple.com/us/podcast.... Google Podcasts: https://podcasts.google.com/feed/aHR0.... Follow John on Twitter: / johnp_driscoll Follow David on Twitter: / healthbizblog #healthcarepodcast #healthcareindustry #healthcarebusiness #healthcarepolicy #ushealthcare #healthcareeconomics #digitalhealth #health #caretalk #besthealthcarepodcasts #ushealthcare #news #340bprogram #whatisthe340bprogram #healthcarelaw #law #lawyer #socialissues This episode is sponsored by Provider Solutions & Development. Visit info.psdconnect.org/caretalk to learn how Provider Solutions & Development can help you hire better, faster and for good. ABOUT ALLISON HOFFMAN Allison K. Hoffman, an expert on health care law and policy, examines some of the most important legal and social issues of our time, including health insurance regulation, the Affordable Care Act, Medicare and retiree healthcare expenses, and long-term care. Before joining the faculty at Penn Law, Professor Hoffman was on the faculty at the UCLA School of Law and was a Petrie-Flom fellow at Harvard Law School. She also practiced health care law at Ropes and Gray and was a strategy consultant at The Bridgespan Group and the Boston Consulting Group.
The Business & Science Behind the GLP-1 Boom
Introduction to Covered Entities and the 340B Drug Pricing Program - Burrows Consulting
The Future of Medicine Is Already Here w/ Dr. Bertalan Meskó, The Medical Futurist Institute
Think Faster, Talk Smarter with Matt Abrahams
Catholic Mass 101: Learn Every Part of the Mass and What It Means (w/ Fr. Mike Schmitz)
The Data on 340B Contract Pharmacy Restrictions
From Compliance to Resilience: Securing Digital Mission Systems at Military Scale
The 340B Drug Pricing Program: Opportunities and Responsibilities
Targeting the Root Causes of Metabolic Disease w/ Bob Geho, Founder & CEO, Diasome
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
FDA Direct: These 9 Drugs Were Awarded National Priority Vouchers
Preparing for the Pandemic We Haven't Seen Yet w/ Dr. Dan Barouch & Kris Brown, Vector Sciences
The ABCs of 340B: A 101 Webinar on the 340B Drug Discount Program
Building Human-Centered AI Strategies in Commercial Real Estate
Think Fast, Talk Smart: Communication Techniques
CareTalk by CVT, Episode 2: What is SmartCare?
Muscle Movement Is Medicine: The Truth About Healing Joints.... - Talk with Dr. Tammy Penhollow
Innovation, Data, and the Business of Wounds
How Data Analytics Support Your 340B Program
